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INTRAOPERATIVE ULTRASONOGRAPHY IN PANCREATIC 
SURGERY: STAGING AND RESECTION GUIDANCE
O. Kolesnik*, A. Lukashenko, A. Shudrak, T. Golovko, G. Lavryk, J. Huralevych
National Cancer Institute, Kyiv 03025, Ukraine
Background: Intraoperative ultrasound examination (IOUS) is indispensable part of modern surgical interventions in tumors of he-
patopancreatobiliary zone. In this study retrospective analysis of IOUS efficiency in surgical treatment of pancreatic tumors was 
provided. Materials and Methods: In the period from January 2013 till November 2015 in the National Cancer Institute IOUS was 
applied during 76 surgical interventions: for pancreatic head tumors — in 46 (60.5%) patients, for body/tail pancreatic tumors — 
in 20 (26.3%) patients, in 10 (13.2%) patients — for periampullary zone neoplasms. In IOUS we performed primary tumor assessment 
(localization, degree of tumor spreading to superior mesenteric vessels, hepatoduodenal ligament vessels, additional foci occurrence 
in pancreas), and liver metastases detection. Surgical interventions were performed: pancreatoduodenectomy in 52 (68.4%) patients, 
radical antegrade modal pancreatosplenectomy — in 14 (18.4%) patients. Results: IOUS allowed determining additional tumor foci 
in pancreas in 2 (2.6%) patients, in 8 (10.5%) observations tumor invasion into portal or superior mesenteric vein was determined. 
In 21 (27.6%) patient additional hepatic neoplasms were detected (in half of cases — 11.8%, metastases). These findings resulted 
in change of surgical intervention extent in 23 (30.3%) patients: expansion to combined resections in 14 (18.4%) patients, reduction 
to symptomatic operations in 5 (6.6%) cases, organ-preserving operations were performed in 4 (5.3%) patients. Variant anatomy 
of hepatic arterial blood supply was determined in 41 (53.9%) patients that necessitated performance correction of resection stages 
for preservation of adequate hepatic blood supply. Conclusions: IOUS is a highly-precise diagnostic method substantively influencing 
operation course in pancreatic tumors, enabling surgeon to provide adequate staging and permanent correction of operation course.
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Precise preoperative staging of tumor process 
is a basic principle for choice of optimal extent for 
surgical intervention. Intraoperative ultrasound exa-
mination (IOUS) in a number of situations is superior 
to spiral computer tomography (CT) and magnetic 
resonance tomography (MRI) in terms of sensitivity 
and specificity, at present it is essentials for surgical 
interventions for hepatopancreatobiliary tumors [1]. 
Enhancement of radiologic methods precision re-
mains actual problem, especially for diagnostics 
of pancreatic tumor spreading, where currently the 
term “borderline resectable tumors” remains gene-
rally accepted [2].
IOUS was applied for the first time in 1960s to lo-
calize kidney stones. At early stages the novel method 
was rather skeptically met by surgeons, and only closer 
to 1970s IOUS began to gain increasing popularity, 
which was facilitated by equipment improvement, 
introduction of new, higher frequencies for examina-
tion, and imaging quality increase. Nevertheless for 
the first time IOUS in pancreatic tumors was applied 
only in 1980 [3, 4].
According to a number of authors in operative in-
terventions in hepatopancreatobiliary zone IOUS could 
alter surgical intervention plan in 4.5–40% of cases [5, 
6]. IOUS of pancreas allows precise main pancreatic 
duct localization in glandular tissue, determines its 
relation towards tumor, clarifies occurrence and 
degree of canal blockage with tumor, and possible 
retention cysts occurrence. Application of Doppler 
IOUS regimen extends possibilities for intraoperative 
localization of vessels of hepatoduodenal ligament and 
mesentery, allows determining their variant anatomy 
and also occurrence and degree of tumor invasion into 
main visceral vessels. At liver metastases detection 
IOUS significantly exceeds CT or MRI in sensitivity 
parameter, reaching 94–96% even at small foci with 
3–5 mm dimensions [7].
To determine effectiveness of IOUS in pancre-
atic cancer surgery, we analyzed our own experience 
of this method application.
MATERIALS AND METHODS
In the period from January 2013 till November 
2015 in the clinics of the National Cancer Institute 
IOUS procedure was applied for 76 surgical interven-
tions for pancreatic tumor. Average patients’ age 
was 62.5 ± 3.6, males to females ratio was 33/43, 
respectively. In 46 (60.5%) patients the primary tu-
mor was localized in pancreatic head, in 20 patients 
(26.3%) — in pancreatic body/tail, 13.2% of cases 
corresponded to periampullary zone tumors (major 
duodenal papilla, terminal choledoch units, and 
duodenum). This study was approved by local ethi-
cal committee. Informed consent was obtained from 
each patient. Patients’ characteristics are presented 
in Table 1. Whole malignancies in presented series 
were confirmed histologically.
All the patients received standard preoperative 
examination that mandatory included multi-slice ab-
dominal CT with intravenous contrast enhancement, 
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followed by three-dimensional vascular reconstruc-
tion. At surgical interventions planning CT data that 
were received no later than 4 weeks prior to surgery 
date were used. CT assessment was carried out 
by radiologists with broad experience in diagnostics 
of hepatopancreatobiliary tumors. Three patients 
apart from CT additionally received 18-fluorode-
oxyglucose positron emission computer tomography 
(PET-CT), 21 (26.4%) patients additionally received 
MRI. 34 (44.7%) patients received percutaneous 
transhepatic biliary drainage for biliary decompres-
sion for tumors complicated by obstructive jaundice 
at preoperative stage.
Table 1. Patients characteristics
Characteristics n %
General patients’ number in the study 76
Average age, years 62.5 ± 3.6
Ratio males/females 33/43
Tumor localization
Pancreatic head 46 60.5
Periampullary zone: 10 13.2
• major duodenal papilla 5 6.6
• distal choledochus 3 3.9
• duodenum 2 2.6
Pancreatic body/tail 20 26.3
Additional examination methods
MRI, magnetic resonance cholangiopancreatography 
(MRCP)
21 27.6
PET-CT 3 3.9
Method of biliary decompression at mechanical jaundice
Percutaneous transhepatic biliary drainage 34 44.7
Biliary stenting 5 6.6
IOUS procedure. IOUS was performed with de-
vise FlexFocus 400 and UltraView 800 (BK, Denmark) 
with application of convex, biplane and laparoscopic 
transducers. Transducers technical characteristics are 
presented in Table 2.
Study protocol was standardized for all the pa-
tients. Major IOUS steps included clarification of tumor 
localization in pancreas, assessment of its texture, 
relationships with vessels of hepatoduodenal liga-
ment, mesentery, and celiac artery. Additional IOUS 
target was assessment of healthy gland parenchyma, 
additional tumor foci presence, major pancreatic duct 
localization, its dilatation degree, and cysts occurrence 
in pancreatic tissue. After pancreas examination liver 
IOUS was carried out for metastasis detection and 
differential diagnostics with benign liver neoplasms.
IOUS technique. After surgical site preparation 
IOUS through gastric wall was started, using stomach 
as acoustic window; direct pancreas examination was 
performed after gastrocolic ligament mobilization. 
As main acoustic markers the portal veins were used, 
starting from confluence and further along splenic and 
superior mesenteric veins. Additional acoustic mar-
kers were superior mesenteric artery, gastroduodenal 
artery, and celiac artery. After regional lymph nodes 
assessment (lymph nodes of hepatoduodenal liga-
ment, aortocaval group, etc.), choledoch and Wirsung 
duct were examined.
At liver IOUS for better visualization of frontal organ 
surface falciform ligament transection was performed. 
Further at right lobe IOUS the liver was slightly translo-
cated by round ligament abduction to the left. Optimal 
image obtaining was achieved by liver capsule irriga-
tion with 20 ml of saline. First point of orientation was 
entry of median hepatic vein, exploration was provided 
starting from “initial triangle” formed by three hepatic 
veins toward periphery using inferior vena cava as addi-
tional orientation. Segmental portal branches that cen-
trifugally directed from portal fissure toward periphe ry 
were explored segment by segment, starting from 
entry; at that topographical marking was performed 
according to Couinaud’s classification. Important 
step was determination of Glissonian pedicle to every 
liver segment. Detection of all auxiliary structures not 
related to Glisson’s entity further was explored in more 
detail by duplex regimen application. At parenchyma 
assessment main consideration was given to masses 
with texture different from normal liver parenchyma.
Table 2. Technical characteristics of transducers
Characte-
ristics
Frequency, 
MHz
Focal length, 
mm
Contact area, 
mm
Linear 12–5 2–55 50 × 4
Convex 6–2 12–200 65.5 × 13
Biplane 10–3.75 5–95 5 × 30 × 2
Laparosco-
pic — 4-Way
10–4.3 5–95 5 × 30
IOUS was completed with determination of ana-
tomic variant of common hepatic artery, proper hepatic 
artery and lobular hepatic arteries, and also the variant 
of portal vein confluence. In case of pancreatic tumor 
contact with hepatic artery, superior mesenteric artery 
of celiac artery, more detailed assessment of blood 
flow changes in these vessels and also of blood flow 
in liver peripheral vessels was conducted for confirma-
tion of true arterial invasion.
In case of tumor contact with the wall of portal vein 
or dorsal mesenteric vein we determined the type 
of venous invasion according to Nakao classifica-
tion [8], followed by choice of optimal tactics for portal 
resection/reconstruction.
Before the end of surgical intervention we performed 
ultrasound duplex assessment of liver arterial blood flow 
to exclude possible thrombosis resulting from surgical 
manipulations (lymph node dissections, angioplasty, 
etc). During implementation of portal resection/recon-
struction we assessed portal blood flow both in resection 
zone, and in peripheral intrahepatic portal branches.
RESULTS
Average duration of the IOUS procedure was 
17 ± 5 min. In 10 cases IOUS were conducted for 
periampullary tumors (adenocarcinoma of major duo-
denal papilla, terminal choledoch, and duodenum). 
In 66 cases of primary pancreatic tumors, the ductal 
adenocarcinoma was in 68.2% (45 patients). These 
tumors in 80% were hypoechoic comparing to sur-
rounding pancreatic tissue, and were hyperechoic 
in 15.6% of cases. Neuroendocrine tumors (NET) 
comprised 18.2% (12 patients); at that 91.7% of tu-
mors were hyperechoic. In other pancreatic tumors 
all neoplasms were hyperechoic (Table 3).
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Table 3. IOUS tumor characteristic based on morphologic characteristics
Tumor Hypoechoic tumors, n (%)
Hyperechoic 
tumors n (%) Total, n
Pancreatic ductal adenocarcinoma 38 (84.4) 7 (15.6) 45
NET 11 (91.7) 1 (8.3) 12
Acinic cell adenocarcinoma 2 (66.6) 1 (33.3) 3
Solid pseudopapillary tumor 5 (100.0) − 5
Pancreatic sarcoma 1 (100.0) − 1
Periampullary zone adenocarcinoma 10 (100.0) − 10
Total 76
In 21 patients (27.6%) IOUS discovered additional 
neoplasms in liver. Metastatic liver affection was di-
agnosed in 9 patients (11.8%); from 6 of them (7.9%) 
we revealed ductal adenocarcinoma metastases, 
in 3 patients (3.9%) metastases of NET. These findings 
resulted in extension of surgical procedure in 4 patients 
(5.3%), and in decrease of surgical procedure in 5 pa-
tients (6.6%). Benign liver neoplasms were diagnosed 
in 12 cases (15.8%), including 5 cases that previously 
were assessed as “suspicious” for metastatic liver af-
fection by CT and MRI. In 4 cases with Doppler IOUS 
the differential diagnostics of hepatic cysts with tumor 
metastases was conducted. More detailed description 
of obtained results is presented in Table 4.
During IOUS additional pancreatic tumor lesions 
were detected in 2 patients (2.6%) that led to exten-
sion of resection in both cases. In two other cases 
at palpatory examination we failed to detect tumor foci 
that were previously determined by CT. In this situa-
tion IOUS allowed realizing meticulous intraoperative 
navigation resulting in clear surgical resection margin 
(R0) (Fig. 1).
During IOUS variant anatomy of right branch 
of proper hepatic artery was detected in 36.8% cases, 
of left branch of proper hepatic artery — in 17.1% 
cases that in all the patients necessitated resection 
performance correction for preservation of adequate 
hepatic blood supply.
Table 4. Data received at IOUS
Data received at IOUS n %
The following lesions were additionally detected in liver: 21 27.6
• metastases of pancreatic ductal adenocarcinoma 6 7.9
• metastases of neuroendocrine pancreatic tumor 3 3.9
• hepatic cysts 4 5.3
• hepatic hemangiomas 8 10.5
The following lesions were additionally detected in pan-
creas
2 2.6
Tumor invasion into portal system veins: 8 10.5
• type А by Nakao 4 5.3
• type B by Nakao 2 2.6
• type C by Nakao 3 3.9
Surgical intervention was changed after IOUS 23 30.3
Surgical intervention was expanded: 14 18.4
• pancreas resection + liver resection 4 5.3
Whipple procedure  total pancreatectomy 1 1.3
Whipple procedure  combined Whipple procedure with 
resection of pancreatic head/tail
1 1.3
Whipple procedure  combined Whipple procedure with 
resection of portal/upper mesentery veins
6 7.9
RAMPS  combined RAMPS with resection of portal/up-
per mesentery
2 2.6
Surgical intervention was reduced: 9 11.8
• spleen-preserving distal pancreatic resection 4 5.3
• symptomatic surgery 5 6.6
Arterial variation in the liver blood supply was determined: 41 53.9
• arterial variation of right branch of proper hepatic artery 28 36.8
• arterial variation of left branch of proper hepatic artery 13 17.1
Note: RAMPS — radical antegrade modular pancreatosplenectomy.
Fig. 1. IOUS navigation in pancreatic body tumor with maximal 
diameter 1.1 cm that is not detectable during palpation; SMV — 
superior mesenteric vein; SV — splenic vein, Tr — tumor
In 8 patients IOUS revealed tumor invasion into por-
tal or superior mesenteric vein that led to expanding 
of surgical resection up to combined one with resec-
tion/reconstruction of portal system veins.
Characteristics of surgical treatment and 
postoperative complications. 52 (68.4%) patients 
with localization of primary tumor in pancreatic head 
or in periampullary zone were subjected to pancreato-
duodenectomy (PD); for tumors of distal departments 
of pancreas in 14 patients radical antegrade modular 
pancreatosplenectomy (RAMPS) was performed 
(Table 5). In 4 cases of solid pseudopapillary tumor, and 
also in 2 cases of NET, localized in pancreatic body/tail, 
IOUS helped to confirm the absence of tumor encase-
ment of splenic artery/vein; therefore spleen-preserving 
distal pancreatic resections were performed.
In two patients at PD planning additional foci in pan-
creatic head/tail were identified with IOUS. In one 
case intervention was expanded to total pancreatec-
tomy at multifocal growth form of pancreatic cancer. 
In  another case at confirmation of 3 NET foci in pan-
creatic head with dimensions from 3 to 7 cm and pre-
sence of 2 additional foci in pancreatic isthmus and 
tail — of 10 and 5 mm, respectively, resection extent 
was expanded to combined PD with resection of pan-
creatic body and resection of portion of pancreatic tail 
with spleen preservation (Fig. 2).
Table 5. Surgical procedure, postoperative complications rate
Surgical procedure, postoperative complications rate n %
Radical resection: 71 93.4
• whipple procedure 52 68.4
• RAMPS 14 18.4
• total pancreatectomy 1 1.3
• spleen-preserving distal pancreatectomy 4 5.3
Symptomatic operations 5 6.6
Multivisceral resections:
• left-sided nephrectomy 3 3.9
• diaphragm resection 2 2.6
• colectomy 5 6.6
• right-sided hemihepatectomy 1 1.3
• proximal gastric resection 1 1.3
• atypical hepatic resection 3 3.9
Resection of portal system veins: 8 10.5
• linear vein resection 5 6.6
• circular vein resection 3 3.9
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Surgical procedure, postoperative complications rate n %
Morphological examination data (71 radical resection):
• R0 resection 64 90.1
• R1 resection 7 9.9
True invasion into vascular wall (from 8 cases of portal re-
section):
7 87.5
• invasion into vascular adventitia 4 57.1
• invasion into proper muscular layer 3 42.9
Postoperative complications 29 38.2
Pancreatic fistula (70 cases of pancreatic resection), from 
them:
26 37.1
• type А 20 76.9
• type В 4 15.4
• type С 2 7.7
Acute pancreatitis 11 14.7
Delayed gastric empting 15 19.7
Intraabdominal fluid collection 10 13.2
Surgical wound infection 5 6.6
Need for postoperative additional US-guided drainage 7 9.2
Need for relapatotomy 1 1.3
Postoperative mortality 1 1.3
Fig. 2. Intraoperative photo: Whipple procedure with pancreatic 
tail resection and preservation of splenic vein and splenic artery, 
SA — splenic artery, SV — splenic vein
In the presence of IOUS data about involvement 
of portal or superior mesenteric vein into tumor pro-
cess in case of tumor affection of less than 180 de-
grees of vessel circumference the linear resection 
(Fig. 3, a, b) was performed of portal or superior 
mesenteric vein (Fig. 4, a) in 5 patients (6.6%), and 
3 patients with larger affection type — B-C by Nakao 
classification — were subjected to portomesenterial 
anastomosis “end-to-end” (Fig. 4, b, c, d).
a
b
Fig. 3. Tumor is located between choledoch and superior 
mesenteric vein with moderate deformation of the vascular wall 
(type A according to Nakao classification); SMV — superior me-
senteric vein, Ch — choledoch, Tr — tumor (a). Linear resection 
of portal and superior mesenteric veins (intraoperative picture 
of the case; arrows indicate vascular suture line); P — pancreatic 
stump, pha — proper hepatic artery (b)
At metastases in liver in 3 cases (in 2 patients with 
pancreatic NET and in one patient with ductal adeno-
carcinoma) atypical liver resections were performed; 
in one case it was multivisceral resection: RAMPS with 
right-sided hemihepatectomy at metastases of meta-
static high-differentiated NET. In other three cases 
after confirmation of adenocarcinoma metastases into 
liver surgical intervention was reduced to palliation.
According to the data of final morphological exa-
minations R0 resection was achieved in 64 (90.1%) 
from 71 patients that were subjected to radical surgical 
interventions. At resection of portal system veins true 
invasion was confirmed in 7 of 8 cases, at that in 4 ob-
servations the tumor invaded into vessel adventitia, 
and in 3 cases — into muscular layer (Fig. 4, e).
Major complication was pancreatic fistula — in 37% 
of cases, predominantly of low and moderate seve-
rity grade (type А-B according to International Study 
Group on Pancreatic Fistula — ISGPF) [9]; only in 9.2% 
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the need for additional US-guided drainage arose. 
Total postoperative lethality was 1.3%
DISCUSSION
Preoperative staging at pancreatic cancer remains 
actual despite of emergence of novel diagnostics 
methods; explorative interventions continue to make 
significant share (20–57%). Major difficulties are 
related to determination of local resectability [10] 
and distant metastases detection [11] that supports 
the need to continue studies in this area. Experience 
in diagnostics of neoplasms of hepatopancreatobiliar 
system is very important because it reliably increases 
accuracy of CT and MRI examinations in highly spe-
cialized centers [12].
Determination of the extent of pancreatic neoplasm 
encasement of superior mesenteric vessels and also 
of hepatoduodenal ligament vessels — is one of the 
key moments in tumor resectability evaluation. Modern 
a
b
c
d
e
Fig. 4. Advanced cancer of pancreatic body, involvement of the superior mesenteric vein (SMV); SMA — superior mesenteric artery, 
Tr — tumor (a). RAMPS was performed with circular resection of superior mesenteric vein; vascular suture line is indicated with 
arrow (intraoperative picture of the case): PV — portal vein, SMV — superior mesenteric vein, SMA — superior mesenteric artery, 
Tr — coeliac trunk, LGA — left gastric artery (b). Zone of circular portomesenterial anastomosis (indicated with arrow). IOUS control 
after circular resection/reconstruction. Estimation of portal blood flow sufficiency (c). Macroscopic specimen — circular mesen-
teric vein resection in RAMPS (arrows indicate resection margins of superior mesenteric vein; d). Pathomorphological examination 
confirmed true invasion into muscular layer of superior mesenteric vein wall (arrow indicates tumor cells; e)
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procedures CT and MRI with application of technology 
of three-dimensional reconstruction have high sensiti-
vity and specificity for vascular invasion diagnostics [13]. 
At the same time IOUS demonstrated superiority over 
CT in the study of Soyer et al.; tumor encasement 
of vessels was additionally detected in 15% of patients 
with absence of invasion signs at CT [14]; in our study 
this index comprised 10.5%. At further morphological 
examination true invasions were confirmed in 87.5% 
of cases that was somewhat higher than figures re-
ported in previous studies (26–85%) [13, 14]. Thereby 
IOUS is effective method that allows determining the 
presence of true tumor invasions into vessels. In case 
of tumor encasement of portal system veins IOUS al-
lowed classification of portal invasion type and choosing 
optimal ways for portal resection/reconstruction.
In 41 (53.9%) patients in our study the presence 
of hepatic artery variant anatomy required special at-
tention at pancreas mobilization. The slightest trauma 
of variantly located both right hepatic artery at PD and 
left hepatic artery at distal pancreatic resections subse-
quently leads to arterial thrombosis with development 
of necrosis of appropriate liver portion. Modern IOUS 
enables intraoperative Doppler control of satisfactory 
arterial and portal blood flow in great and peripheral 
hepatic vessels after completion of hepatoduodenal 
ligament lymph dissection, and also in cases of resec-
tion/reconstruction of portal system veins [12].
At metastatic liver affection IOUS supersedes CT, MRI 
in terms of sensitivity and specificity by 5–30% [10, 11, 
15, 16]. Whereas CT/MRI data are limited in determina-
tion of foci less than 2 cm, IOUS augments visualization 
threshold at solid foci up to 3–5 mm, at cystic foci — 
up to 1–3 mm [6]. Metastases of pancreatic cancer in the 
majority of cases were hypoechoic (84.4% of cases in our 
study) that required differential diagnostics with heman-
giomas, hepatic adenomas, cirrhotic nodules and other 
benign liver tumors. Benign hepatic formations do not 
engage central vascular structures; they only alter their 
contour, while malignant tumors trend to invade vascular 
lumen with partial occlusion and also with thrombosis. 
Application of hepatic IOUS allows for precise localization 
of affected segment according to Coinaud classification, 
and also to determine tumor topography with respect 
to hepatic veins and portal structures.
In this study additional hepatic neoplasms were 
determined in 27.6%, at that metastatic liver af-
fection comprised about half of cases (11.8%). 
The fact that these neoplasms with dimensions from 
0.5 to 1.5 cm were not previously visualized by preope-
rative CT, MRI and PET-CT, and also by palpation de-
serves special attention. IOUS sensitivity at pancreatic 
NET varies from 80 to 95%, major limitation is focus di-
mensions [17]. Study of Kauhanen et al. demonstrated 
that PET-CT has higher sensitivity than CT and MRI 
for diagnostics of distal NET metastases [18]. In one 
patient with NET in our study IOUS allowed determining 
additional foci in pancreas with dimensions 1 cm and 
0.5 mm (these lumps by CT were regarded as cysts).
At pancreatic cancer important prognostic factor 
is resection margin status. In case of small tumors that 
can hardly be discerned by palpation the control of ade-
quate (R0) margin may be complicated. In our study IOUS 
appeared to be the indispensable method of intraopera-
tive navigation for tumors less than 1 cm in 2 cases. Ad-
ditional IOUS data led to alteration of extent of surgery 
in one third of patients (30.1%): extent of resection was 
expanded to combined resection in 18.4% of cases, and 
it was reduced to symptomatic in 6.6%. In 5.6% of cases 
IOUS data allowed to perform organ-saving operations. 
Surgical intervention correction according to variant 
vascular anatomy was required in 53.9% of cases.
According to the data received in our study IOUS 
proved to be the method that is convenient to use, and 
which only insignificantly extends operation period. Ad-
ditional advantages of this method over CT and MRI were 
dynamic image obtaining with possibility of correction 
and new data acquisition at any moment of operation.
CONCLUSIONS
At pancreatic tumors IOUS has higher sensiti vity 
and specificity than preoperative transabdominal 
US examination, CT, MRI, and also it precedes capaci-
ties of operational visual and palpatory diagnostics.
IOUS allows carrying out intraoperative assessment 
of variant vessels anatomy with appropriate correction 
of operation strategy, and also Doppler control estima-
tion of vascular perfusion before operation completion.
At present IOUS is indispensable part of all diag-
nostic and treatment complex for pancreatic tumors. 
This is a safe method which insignificantly extends time 
of operative intervention.
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